Skip to main content
    V

    Vor Biopharma Inc (VOR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $18.18
    -0.79 (-4.16%)

    Market Cap: $1.19B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Vor Biopharma Inc (VOR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Vor Biopharma (VOR) has a market cap of $1.19B and an enterprise value of $1.11B. Its share count is up 793.02% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 6.62% below the market cap, as cash exceeds debt.

    Market Cap$1.19B
    Enterprise Value$1.11B
    Latest price (Nov 17, 2026)$18.18

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateOct 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 9.88% in the quarter ended Sep 30, 2026 and grew 317.49% a year over 2 years.

    Shares Outstanding59.67M
    Shares Change (YoY)+793.02%
    Shares Change (QoQ)+9.88%
    Share Count Growth (2Y CAGR)+317.49%

    Price Statistics

    The stock is up 81.62% over 52 weeks and trades 7.86% below its 50-day average.

    Beta (1Y)1.62
    52-Week Change+81.62%
    1-Month Change+0.78%
    3-Month Change-22.90%
    6-Month Change+28.66%
    5-Year Change-93.74%
    Total Return (1Y)+81.62%
    Total Return (3Y CAGR)-19.76%
    Total Return (5Y CAGR)-42.18%
    Return vs SPY (1Y)+87.78%
    Max Drawdown (1Y)-33.41%
    Max Drawdown (3Y)-94.69%
    Sharpe Ratio (1Y)0.76
    Correlation with SPY (1Y)0.25
    50-Day Average$19.73
    200-Day Average$17.59
    52-Week Range$6.50 to $26.00
    RSI (14 Days)41.7
    Average Volume (20 Days)720.87K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 13.50x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio13.50x
    Quick Ratio13.50x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on Assets (ROA)272.76%
    ROA (5Y Average)-70.09%
    ROIC (5Y Average)337.44%

    Scores

    VOR has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$23.00K
    Operating Income-$177.42M
    Pretax Income$1.35B
    Net Income$1.35B
    Reported EPS (TTM)$305.10

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$78.98M
    Total Debt$0
    Net Cash$78.98M
    Net Cash Per Share$1.32
    Working Capital$454.18M
    Shareholder Equity-$137.17M
    Total Assets$496.31M
    Total Liabilities$633.49M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $507.00K of capital spending, operating cash flow left -$119.68M of free cash flow.

    Operating Cash Flow-$119.17M
    Capital Expenditures$507.00K
    Free Cash Flow-$119.68M
    FCF Per Share-$2.02
    Depreciation and Amortization$1.54M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    VOR does not pay a dividend. Its free cash flow yield is -11.03%.

    FCF Yield-11.03%
    Buyback Yield-39.79%
    Shareholder Yield-39.79%

    Stock Splits

    The last split was a 1-for-20 reverse split on Sep 19, 2025.

    Last Split DateSep 19, 2025
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About VOR

    What is VOR's market cap?

    Vor Biopharma has a market cap of $1.19B. Its enterprise value, which adds debt and subtracts cash, is $1.11B.

    How many shares of VOR are outstanding?

    Vor Biopharma has 59.67M shares outstanding. The count is up 793.02% from a year earlier.

    Does VOR pay a dividend?

    No. Vor Biopharma does not pay a dividend.

    How much debt does VOR have?

    Vor Biopharma has $0 of total debt and $78.98M of cash and equivalents, a net cash position of $78.98M.